Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats
Conclusions: Treatment with estrogen and vildagliptin provided more beneficial effects in the inhibition of oxidative stress, apoptosis, and cardiac mitochondrial dysfunction, and preserved cardiac contractile performance in estrogen-deprived insulin-resistant female rats.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
More News: Cardiology | Depression | Eating Disorders & Weight Management | Fortamet | Heart | Insulin | Men | Menopause | Metformin | Nutrition | Obesity | OBGYN